Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,111
datasets available to search
ShareScore release 0.9.0
Dataset results
2,111 results for “bevacizumab”
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
ClinicalTrials.gov study NCT00548418. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
ClinicalTrials.gov study NCT00448591. IPD Sharing: Not stated. Countries: 36. Publications: 2.
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00445848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
ClinicalTrials.gov study NCT05523440. IPD Sharing: NO. Countries: 1. Publications: 1.
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05824559. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT01621880. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00367601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
ClinicalTrials.gov study NCT00631371. IPD Sharing: Not stated. Countries: 30. Publications: 4.
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-
ClinicalTrials.gov study NCT01663727. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00861705. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
ClinicalTrials.gov study NCT00667394. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer
ClinicalTrials.gov study NCT00055692. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab
ClinicalTrials.gov study NCT01292798. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
ClinicalTrials.gov study NCT02559180. IPD Sharing: NO. Countries: 1. Publications: 7.
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03434379. IPD Sharing: YES. Countries: 17. Publications: 8.
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00565851. IPD Sharing: Not stated. Countries: 3. Publications: 3.
A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer
ClinicalTrials.gov study NCT00548548. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03288987. IPD Sharing: NO. Countries: 1. Publications: 1.
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
ClinicalTrials.gov study NCT01222715. IPD Sharing: Not stated. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.